Added to YB: 2020-09-06
Pitch date: 2020-09-06
ALXN [bullish]
Alexion Pharmaceuticals, Inc.
+63.35%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. It offers ULTOMIRIS for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) and SOLIRIS for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD).
Market Cap
$40.3B
Pitch Price
$111.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
59.23
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ALEXION PHARMACEUTICALS INC ALXN
A summary for this pitch has not been created yet.
Read full article (0 min)